Resources

In the fast-paced world of antibody research, time and efficiency are critical. To meet the growing demand for rapid, high-quality solutions, Biointron has launched a series of innovative small-scale antibody production packages under the RushMab™ brand.

Biointron and Cyagen have joined forces to create a breakthrough platform for discovering fully human antibodies.

RSSL has today announced that it has secured funding from Innovate UK, the UK’s national innovation agency, to establish the country’s first Novel Foods Expert Network for Regulatory Challenges (NFX UK).

The BIA is driving progress across life sciences, from shaping policy in engineering biology and advocating for balanced perspectives in the Covid Inquiry to exhibiting UK innovation at JP Morgan Healthcare Week. 

In this blog, Maddie Cass, Senior Policy and Public Affairs Executive at the BIA, shares our perspective on the recent EngBio public trust survey findings conducted by the DSIT.

UK dealmakers are at the heart of JPM, the Government rolls out AI plan and new MHRA Chair sets priorities.

In this blog Izzy Webb, Deputy Director for technology, strategy and security in the Department for Science, Innovation and Technology (DSIT), discusses the UK Government's survey on engineering biology, outlining its limited public awareness but sharing optimism about its potential to address societal challenges.

Excelra has partnered with Orogen Therapeutics, an innovative DNA-Encoded Library (DEL) and AI-driven biotechnology company currently developing a portfolio of best-in-class small molecule treatments.

As we engage as an Association in the development of the life science sector plan, the 10 year NHS plan and the UK’s industrial strategy this winter, this week I’ve been reflecting on what recent NHS announcements on adoption of innovation tell us.

With a new Labour Government in place, this year’s event set the stage for impactful collaboration with MPs and policymakers. Read on to learn how we’re keeping life sciences at the top of the agenda.

The potential presented by Engineering Biology (EngBio), both globally and for the UK, is difficult to overstate. Realisation of this potential across sectors as diverse as health, energy, materials, chemicals production and waste management, will be achieved by providing the right tools to help companies of all sizes as they innovate and translate those innovations to commercial scale.

In this guest blog, Luis Lacerda and Suzanne Farid from UCL explore the transformative potential of engineering biology and its critical role in addressing sustainability challenges in medicines manufacturing.

A new industry briefing note developed by Pioneer Group in collaboration with the UK chemicals sector community highlights the urgent need for the sector to transition to a more sustainable, circular economy.

CN Bio, a leading provider of Organ-on-a-chip Systems and solutions that accelerate drug discovery and development workflows, today announced the launch of its PhysioMimix® Bioavailability assay kit: Human 18.

Ingenza welcomes Lisa Fraser as she takes on the role of Senior Project Manager, effective immediately.

GitLife Biotech Ltd. has appointed Beatrix Ellis as its new CEO. With extensive experience in commercial strategy and business development, this appointment marks a pivotal moment for GitLife.

Read the latest antibody industry report which report which aims to explore the events and trends of the biopharmaceutical industry in Q3 (July, August, September). Besides PiaSky, Vyloy, Imdelltra, Tribuvia, and ivonescimab, five more novel antibody drugs have been approved this year.

In this blog, Izzy Webb outlines why the UK has published voluntary guidance to promote DNA synthesis and who the guidance is intended for.